After Thanksgiving break, instruction will become 100% on-line. The spring 2021 semester will begin on January 25.
For more information, visit coronavirus.uiowa.edu or view pharmacy-specific quick links.
Reza Nejadnik is a Biomedical and Pharmaceutical Scientist. His research area is protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces. Reza Received his PhD from the University of Groningen in the Netherlands back in 2009. Following a few years of research in the area of proteins, nano and biomaterials at The University of Texas, Northwestern University and Radboud University Nijmegen, Reza Joined the Leiden Academic Center for Drug Research in order to lead a European public-private partnership project (COMPACT) that addressed the current challenges with formulation and delivery of macromolecules. In the 4-year period of the COMPACT project, Reza’s research focused on characterization and understanding of protein aggregation in complex formulations as well as protein-material interactions. Reza then joined the Global Biologic Drug Product Development team of Sanofi and headed a formulation and process development laboratory in the Company’s R&D hub in Frankfurt, Germany. He developed early formulations and drug product manufacturing processes for several molecules in various modalities including antibodies and nanobodies. Reza is a new member of the Department of Pharmaceutical Sciences and Experimental Therapeutics. He currently works remotely and is expected to arrive in Iowa City in near future.